President Joe Biden says for many Americans the cost of one drug can be “the difference between life and death” as his administration announces the first drugs that’ll be targeted for price negotiations in an effort to cut Medicare costs
FILE- Bottles of medicine ride on a belt at a mail-in pharmacy warehouse in Florence, N.J., July 10, 2018. President Joe Biden's administration will announce on Tuesday, Aug. 29, 2023, the first prescription drugs being targeted by the U.S. government for price negotiations as part of an effort to lower Medicare costs.
The diabetes treatments Jardiance from Eli Lilly and Co. and Merck's Januvia made the list, along with Amgen’s autoimmune disease treatment Enbrel. Other drugs include Entresto from Novartis, which is used to treat heart failure. Medicare spent about $10 billion in 2020 on Eliquis, according to AARP research. The drug treats blood clots in the legs and lungs and reduces the risk of stroke in people with an irregular heartbeat called atrial fibrillation.
About 9% of Medicare beneficiaries age 65 and older said in 2021 that they did not fill a prescription or skipped a drug dose due to cost, according to research by the Commonwealth Fund, which studies health care issues. The new drug price negotiations aim "to basically make drugs more affordable while also still allowing for profits to be made,” said Gretchen Jacobson, who researches Medicare issues at Commonwealth.The pharmaceutical industry has been gearing up for months to fight these rules. Already, the plan faces several lawsuits, including complaints filed by drugmakers Merck and Bristol-Myers Squibb and a key lobbying group, the Pharmaceutical Research and Manufacturers of America, or PhRMA.
Republican lawmakers also have blasted the Biden administration for its plan, saying companies might pull back on introducing new drugs that could be subjected to future haggling. They’ve also questioned whether the government knows enough to suggest prices for drugs.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Biden targets diabetes drug Jardiance, blood thinner Eliquis and 8 others for Medicare price talksThe popular diabetes treatment Jardiance and the blood thinner Eliquis are among the first drugs that'll be targeted for price negotiations in an effort to cut Medicare costs
Baca lebih lajut »
Eliquis, Jardiance among 10 drugs Biden administration will negotiate prices forThe Biden administration has announced the first 10 drugs which will be subject to price negotiations in an effort to slash Medicare costs.
Baca lebih lajut »
Biden administration to target drugs for price negotiations to lower Medicare costsPresident Joe Biden’s administration is set to announce the first prescription drugs being targeted by the U.S. government for price negotiations as part of an effort to lower Medicare costs.
Baca lebih lajut »
Biden administration to target drugs for price negotiations to lower Medicare costsPresident Joe Biden’s administration is set to announce the first prescription drugs being targeted by the U.S. government for price negotiations as part of an effort to lower Medicare costs
Baca lebih lajut »
Biden administration to target drugs for price negotiations to lower Medicare costsPresident Joe Biden’s administration is set to announce the first prescription drugs being targeted by the U.S. government for price negotiations as part of an effort to lower Medicare costs.
Baca lebih lajut »
Biden administration to target drugs for price negotiations to lower Medicare costsPresident Joe Biden’s administration is set to announce the first prescription drugs being targeted by the U.S. government for price negotiations as part of an effort to lower Medicare costs.
Baca lebih lajut »